NDC 0409-1808 - Novocain

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 0409-1808
Package NDCs from labels: 0409-1808-02, 0409-1808-06
Manufacturer: Hospira, Inc.
Effective date: 2007-04-16
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP	Hospira, Inc.	2007-04-16	Human prescription drug label

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0409-1808-02	Novocain	5 in 1 CONTAINER	INJECTION, SOLUTION	5	1
0409-1808-02	Novocain	40 in 1 CASE	INJECTION, SOLUTION	40	1
0409-1808-06	Novocain	50 in 1 TRAY	INJECTION, SOLUTION	50	1
0409-1808-06	Novocain	10 in 1 CASE	INJECTION, SOLUTION	10	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0409-1808	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1	4 package rows	20070426_C80C810A-60E0-49BD-139C-95AEC3A286FC.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Procaine Hydrochloride	ACTIVE INGREDIENT	95URV01IDQ	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Procaine	ACTIVE MOIETY	4Z8Y51M438	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Acetone Sodium Bisulfite	INACTIVE INGREDIENT		NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Chlorobutanol	INACTIVE INGREDIENT	HM4YQM8WRC	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 10 of 13 · 253 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
SODIUM CHLORIDE	SODIUM CHLORIDE	HF Acquisition Co LLC, DBA HealthFirst	7da788fc-3481-527f-e053-2a91aa0af6ac	2025-01-08	Adverse reactions	Name fallback brand name: SODIUM CHLORIDE
DOBUTAMINE	DOBUTAMINE	Hospira, Inc.	dc537761-d5f4-488d-24ab-b2bcd2b17b7a	2024-12-09	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Company	464c2d78-5c88-4668-a039-56dd3c1c9b20	2024-12-03		Name fallback brand name: Sodium Chloride
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Company	99a15716-bbb9-4e33-a48d-20c58b81f392	2024-11-13		Name fallback brand name: Sodium Chloride
Meropenem	MEROPENEM	Hospira, Inc.	e9b6555f-20a1-4415-bb80-3d034cfab95b	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Meropenem	MEROPENEM	Hospira, Inc.	092ebd9b-77a0-4877-afc3-dd8211730f71	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Ertapenem	ERTAPENEM	Hospira, Inc.	178a0356-4f6c-47fb-9913-f325a3c72f7b	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Hospira, Inc.	8eb172da-dcd4-4660-4a8f-ad44a14b4af7	2024-11-06	Adverse reactions	Name fallback brand name: Sodium Chloride manufacturer name: Hospira, Inc.
Cefepime	CEFEPIME	Hospira, Inc.	e80c27e2-164d-4836-ba24-c160d75dc5d3	2024-11-06	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	c44b0fdb-33df-4747-b443-5fb4deb456cb	2024-10-11	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
Docetaxel	DOCETAXEL	Hospira, Inc.	3104aab1-cd6e-4ad2-8e0a-286a0c5d1940	2024-09-19	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Docetaxel	DOCETAXEL ANHYDROUS	Hospira, Inc.	a0ec4bcc-93ea-4c41-a4b6-95ec19491807	2024-08-22	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Carboplatin	CARBOPLATIN	Hospira, Inc.	47677091-fd20-49af-933c-c9dd2be21de9	2024-08-21	Boxed warning, Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Gemcitabine	GEMCITABINE	Hospira, Inc.	d16907e7-a8c8-4039-ace4-cf4e24ba68c0	2024-08-16	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
GEMCITABINE	GEMCITABINE	Hospira, Inc.	a625c92b-c569-4b98-8d2e-2b3f5e12b34f	2024-08-16	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium Chloride	SODIUM CHLORIDE	Baxter Healthcare Corporation	f55bd888-5e01-474d-871b-24654c070178	2024-07-24	Warnings, Adverse reactions	Name fallback brand name: Sodium Chloride
PEMETREXED	PEMETREXED	Hospira, Inc.	3e087418-69ff-47fa-93c2-f28699309433	2024-07-24	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.
Sodium chloride	SODIUM CHLORIDE	Fresenius Kabi USA, LLC	83994d0c-8484-4505-abb5-8a384ed12288	2024-07-22	Warnings, Adverse reactions	Name fallback brand name: Sodium chloride
sodium chloride	SODIUM CHLORIDE	Becton Dickinson and Company	8df7dcf6-8714-6caf-e053-2995a90ab8cc	2024-07-15	Warnings, Adverse reactions	Name fallback brand name: sodium chloride
TAZICEF	CEFTAZIDIME	Hospira, Inc.	1ab5ae3e-e303-4499-4c89-472d7cc1e46c	2024-07-04	Warnings, Adverse reactions	Name fallback manufacturer name: Hospira, Inc.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.